125 related articles for article (PubMed ID: 35600064)
1. Oridonin Inhibits SARS-CoV-2 by Targeting Its 3C-Like Protease.
Zhong B; Peng W; Du S; Chen B; Feng Y; Hu X; Lai Q; Liu S; Zhou ZW; Fang P; Wu Y; Gao F; Zhou H; Sun L
Small Sci; 2022 Jun; 2(6):2100124. PubMed ID: 35600064
[TBL] [Abstract][Full Text] [Related]
2. Epigallocatechin-3-gallate, an active ingredient of Traditional Chinese Medicines, inhibits the 3CLpro activity of SARS-CoV-2.
Du A; Zheng R; Disoma C; Li S; Chen Z; Li S; Liu P; Zhou Y; Shen Y; Liu S; Zhang Y; Dong Z; Yang Q; Alsaadawe M; Razzaq A; Peng Y; Chen X; Hu L; Peng J; Zhang Q; Jiang T; Mo L; Li S; Xia Z
Int J Biol Macromol; 2021 Apr; 176():1-12. PubMed ID: 33548314
[TBL] [Abstract][Full Text] [Related]
3. The inhibitory effects of PGG and EGCG against the SARS-CoV-2 3C-like protease.
Chiou WC; Chen JC; Chen YT; Yang JM; Hwang LH; Lyu YS; Yang HY; Huang C
Biochem Biophys Res Commun; 2022 Feb; 591():130-136. PubMed ID: 33454058
[TBL] [Abstract][Full Text] [Related]
4. Anti-SARS-CoV-2 activities in vitro of Shuanghuanglian preparations and bioactive ingredients.
Su HX; Yao S; Zhao WF; Li MJ; Liu J; Shang WJ; Xie H; Ke CQ; Hu HC; Gao MN; Yu KQ; Liu H; Shen JS; Tang W; Zhang LK; Xiao GF; Ni L; Wang DW; Zuo JP; Jiang HL; Bai F; Wu Y; Ye Y; Xu YC
Acta Pharmacol Sin; 2020 Sep; 41(9):1167-1177. PubMed ID: 32737471
[TBL] [Abstract][Full Text] [Related]
5. Oridonin inhibits SARS-CoV-2 replication by targeting viral proteinase and polymerase.
Zhang Z; Zhang H; Zhang Y; Zhang Q; Liu Q; Hu Y; Chen X; Wang J; Shi Y; Deng C; Gong P; Zhang B; Li X; Zhu B; Ye H
Virol Sin; 2023 Jun; 38(3):470-479. PubMed ID: 37127212
[TBL] [Abstract][Full Text] [Related]
6. Molecular Interactions of Tannic Acid with Proteins Associated with SARS-CoV-2 Infectivity.
Haddad M; Gaudreault R; Sasseville G; Nguyen PT; Wiebe H; Van De Ven T; Bourgault S; Mousseau N; Ramassamy C
Int J Mol Sci; 2022 Feb; 23(5):. PubMed ID: 35269785
[TBL] [Abstract][Full Text] [Related]
7.
Watuguly T; Bare Y; Ratih Tirto Sari D; Kustarini Samsuria I
Pak J Biol Sci; 2022 Jan; 25(9):867-874. PubMed ID: 36098090
[TBL] [Abstract][Full Text] [Related]
8. Dimethyl sulfoxide reduces the stability but enhances catalytic activity of the main SARS-CoV-2 protease 3CLpro.
Ferreira JC; Fadl S; Ilter M; Pekel H; Rezgui R; Sensoy O; Rabeh WM
FASEB J; 2021 Aug; 35(8):e21774. PubMed ID: 34324734
[TBL] [Abstract][Full Text] [Related]
9. Development of a colorimetric assay for the detection of SARS-CoV-2 3CLpro activity.
Garland GD; Harvey RF; Mulroney TE; Monti M; Fuller S; Haigh R; Gerber PP; Barer MR; Matheson NJ; Willis AE
Biochem J; 2022 Apr; 479(8):901-920. PubMed ID: 35380004
[TBL] [Abstract][Full Text] [Related]
10. Effective inhibition of coronavirus replication by
Xu H; Li J; Song S; Xiao Z; Chen X; Huang B; Sun M; Su G; Zhou D; Wang G; Hao R; Wang N
Front Biosci (Landmark Ed); 2021 Oct; 26(10):789-798. PubMed ID: 34719206
[No Abstract] [Full Text] [Related]
11. Coronaviruses resistant to a 3C-like protease inhibitor are attenuated for replication and pathogenesis, revealing a low genetic barrier but high fitness cost of resistance.
Deng X; StJohn SE; Osswald HL; O'Brien A; Banach BS; Sleeman K; Ghosh AK; Mesecar AD; Baker SC
J Virol; 2014 Oct; 88(20):11886-98. PubMed ID: 25100843
[TBL] [Abstract][Full Text] [Related]
12. Catalytic Dyad Residues His41 and Cys145 Impact the Catalytic Activity and Overall Conformational Fold of the Main SARS-CoV-2 Protease 3-Chymotrypsin-Like Protease.
Ferreira JC; Fadl S; Villanueva AJ; Rabeh WM
Front Chem; 2021; 9():692168. PubMed ID: 34249864
[TBL] [Abstract][Full Text] [Related]
13. Biochemical and biophysical characterization of the main protease, 3-chymotrypsin-like protease (3CLpro) from the novel coronavirus SARS-CoV 2.
Ferreira JC; Rabeh WM
Sci Rep; 2020 Dec; 10(1):22200. PubMed ID: 33335206
[TBL] [Abstract][Full Text] [Related]
14. Cell-Based High-Throughput Screening Protocol for Discovering Antiviral Inhibitors Against SARS-COV-2 Main Protease (3CLpro).
Rothan HA; Teoh TC
Mol Biotechnol; 2021 Mar; 63(3):240-248. PubMed ID: 33464543
[TBL] [Abstract][Full Text] [Related]
15. Protease cleavage of RNF20 facilitates coronavirus replication via stabilization of SREBP1.
Zhang S; Wang J; Cheng G
Proc Natl Acad Sci U S A; 2021 Sep; 118(37):. PubMed ID: 34452991
[TBL] [Abstract][Full Text] [Related]
16. Development of a simple, interpretable and easily transferable QSAR model for quick screening antiviral databases in search of novel 3C-like protease (3CLpro) enzyme inhibitors against SARS-CoV diseases.
Kumar V; Roy K
SAR QSAR Environ Res; 2020 Jul; 31(7):511-526. PubMed ID: 32543892
[TBL] [Abstract][Full Text] [Related]
17. Mechanistic Aspects of Medicinal Plants and Secondary Metabolites against Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2).
Malekmohammad K; Rafieian-Kopaei M
Curr Pharm Des; 2021; 27(38):3996-4007. PubMed ID: 34225607
[TBL] [Abstract][Full Text] [Related]
18. Key dimer interface residues impact the catalytic activity of 3CLpro, the main protease of SARS-CoV-2.
Ferreira JC; Fadl S; Rabeh WM
J Biol Chem; 2022 Jun; 298(6):102023. PubMed ID: 35568197
[TBL] [Abstract][Full Text] [Related]
19. Anti-HIV drug repurposing against SARS-CoV-2.
Sang P; Tian SH; Meng ZH; Yang LQ
RSC Adv; 2020 Apr; 10(27):15775-15783. PubMed ID: 35493667
[TBL] [Abstract][Full Text] [Related]
20. Oridonin Inhibits SARS-CoV-2 by Targeting Its 3C-Like Protease.
Zhong B; Peng W; Du S; Chen B; Feng Y; Hu X; Lai Q; Liu S; Zhou ZW; Fang P; Wu Y; Gao F; Zhou H; Sun L
Small Sci; 2022 Jun; 2(6):2270012. PubMed ID: 35942318
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
